A Study of Hemodynamic Cardiopulmonary Exercise for CHD
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06566196
- Status
- Recruiting
Conditions
- Congenital Heart Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cardiac Cath — PROCEDUREPatient will undergo standard of care Cardiac Cath and in addition invasive CPET (Cardiopulmonary exercise testing) will be performed during the procedure.
Study Details
The purpose of this study is to compare the difference in the ability to detect hemodynamic abnormalities between invasive hemodynamic assessments performed at rest versus exercise, to assess the correlation between invasive and noninvasive (Doppler-derived) rest-exercise hemodynamic indices and to compare the association between indices of disease severity and hemodynamic abnormalities identified at rest versus exercise.
Key Dates
- Start date
- Feb 10, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Patients Undergoing Clinically indicated Cardiac Cath
Primary Outcome Measure
Change in left ventricular end-systolic elastance from rest to peak exercise [ Time Frame: Baseline ]
Central Contacts
- ACHD Research Program507-293-2565
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Alexander Egbe, M.B.B.S., M.P.H. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- ATrial Tachycardia PAcing Therapy in Congenital HeartRecruiting · Ian Law · Los Angeles, California
- Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart DiseasesRecruiting · Mayo Clinic · Rochester, Minnesota
- Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart DiseasePHASE1 · Recruiting · HeartWorks, Inc. · Rochester, Minnesota
- A Study of Invasive Hemodynamic for MACHD RegistryRecruiting · Mayo Clinic · Rochester, Minnesota